Contact Information
  •   11190 Sunrise Valley Dr., Suite 300, Reston, VA, 20191
  •   stp@toxpath.org
  •   703-438-7508
open

Short Education Webinar Series

Home / Education / Short Education Webinar Series
The Society of Toxicologic Pathology (STP) Internet Committee-Web-based Education Subcommittee (WBEC) is pleased to offer these quarterly Short Education Webinar Series as an educational tool to foster collaboration among the toxicologic pathology community. The third of the series will focus on Cardiovascular Safety Assessment which features six presentations from a half-day Continuing Education Course at the STP Annual Symposium held in Boston, Massachusetts (June 2012).

These presentations will explore current understandings of mechanisms of toxicity in the cardiovascular system and put that understanding in the context of how we do our nonclinical assessments. An introductory overview will bring the audience to a common level of understanding around cardiovascular form and function, potential cellular and molecular targets of toxicity, and bridge into the compromised target patient population. Subsequent sessions will explore contemporary and mechanistically diverse areas of toxicity. Individual presentations will review our current level of understanding with respect to mechanisms of toxicity, review how current assessment paradigms address (or not) these mechanisms, and offer biomarker recommendations.

 

Cardiovascular Safety Assessment

 



INTRODUCTION TO THE CARDIOVASCULAR SYSTEM AS A TARGET OF DRUG-INDUCED TOXICITY

Michael C. Boyle, DVM, PhD, DACVP, DABT,
Amgen, Thousand Oaks, CA



CARDIOVASCULAR TOXICITY OF ONCOLOGY DRUGS

Thomas Force, MD, Center for Translational Medicine,
Temple University School of Medicine, Philadelphia, PA



STRUCTURAL CARDIOVASCULAR INJURY AND HEMODYNAMICALLY-ACTIVE DRUGS: THE STRUCTURE-FUNCTION INTERFACE

Heath C. Thomas, DVM, PhD, DACVP,
GlaxoSmithKline, Safety Assessment, King of Prussia, PA



DRUG-INDUCED MITOCHONDRIAL DYSFUNCTION AND CARDIOTOXICITY

Ingrid Pruimboom-Brees, DVM, PhD, DACVP,
Novartis Pharma AG, Basel, Switzerland



CARDIOMYOCYTE CALCIUM HANDLING AND CARDIOTOXICITY

Michael Quaile, PhD, GlaxoSmithKline,
Laboratory Animal Sciences, Research Triangle Park, NC



BIOMARKERS OF CARDIOTOXICITY-CHALLENGES FOR PRESENT AND FUTURE

Eric Schultze, DVM, PhD, DACVP, FIATP,
Lilly Research Laboratories, Indianapolis, IN

 

Not a member? Apply today to receive all STP member benefits.

Subscribe to receive updates on new content.

 

Your Private and Secure Networking Platform

  •  11190 Sunrise Valley Drive,
    Suite 300, Reston, VA 20191